nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—ABCB1—colon cancer	0.627	1	CbGaD
Estramustine—ABCB1—Irinotecan—colon cancer	0.0198	0.284	CbGbCtD
Estramustine—ABCB1—Vincristine—colon cancer	0.0173	0.248	CbGbCtD
Estramustine—CYP3A4—Irinotecan—colon cancer	0.0118	0.17	CbGbCtD
Estramustine—ABCB1—Methotrexate—colon cancer	0.0105	0.15	CbGbCtD
Estramustine—CYP3A4—Vincristine—colon cancer	0.0103	0.148	CbGbCtD
Estramustine—MAP1A—embryo—colon cancer	0.0093	0.104	CbGeAlD
Estramustine—MAP1A—smooth muscle tissue—colon cancer	0.00732	0.0818	CbGeAlD
Estramustine—MAP2—embryo—colon cancer	0.00529	0.0591	CbGeAlD
Estramustine—MAP1A—vagina—colon cancer	0.0051	0.0571	CbGeAlD
Estramustine—Developmental delay—Fluorouracil—colon cancer	0.00451	0.0321	CcSEcCtD
Estramustine—Congenital anomaly—Fluorouracil—colon cancer	0.00451	0.0321	CcSEcCtD
Estramustine—MAP1A—liver—colon cancer	0.0043	0.0481	CbGeAlD
Estramustine—ESR1—blood vessel—colon cancer	0.00393	0.044	CbGeAlD
Estramustine—Myelosuppression—Vincristine—colon cancer	0.00392	0.0279	CcSEcCtD
Estramustine—Myelosuppression—Fluorouracil—colon cancer	0.00365	0.0261	CcSEcCtD
Estramustine—Gastrointestinal tract irritation—Capecitabine—colon cancer	0.00335	0.0239	CcSEcCtD
Estramustine—MAP1A—lymph node—colon cancer	0.0033	0.0369	CbGeAlD
Estramustine—MAP2—digestive system—colon cancer	0.00328	0.0367	CbGeAlD
Estramustine—Congenital anomaly—Capecitabine—colon cancer	0.00315	0.0225	CcSEcCtD
Estramustine—Developmental delay—Capecitabine—colon cancer	0.00315	0.0225	CcSEcCtD
Estramustine—Lacrimation—Irinotecan—colon cancer	0.00304	0.0217	CcSEcCtD
Estramustine—Lacrimation—Fluorouracil—colon cancer	0.00291	0.0208	CcSEcCtD
Estramustine—MAP2—vagina—colon cancer	0.0029	0.0324	CbGeAlD
Estramustine—ESR2—epithelium—colon cancer	0.0028	0.0313	CbGeAlD
Estramustine—Embolism—Irinotecan—colon cancer	0.00279	0.0199	CcSEcCtD
Estramustine—Hoarseness—Capecitabine—colon cancer	0.00272	0.0194	CcSEcCtD
Estramustine—ESR2—smooth muscle tissue—colon cancer	0.00269	0.0301	CbGeAlD
Estramustine—ESR2—renal system—colon cancer	0.00259	0.029	CbGeAlD
Estramustine—MAP2—liver—colon cancer	0.00245	0.0274	CbGeAlD
Estramustine—ESR1—embryo—colon cancer	0.00235	0.0262	CbGeAlD
Estramustine—Night sweats—Capecitabine—colon cancer	0.00222	0.0158	CcSEcCtD
Estramustine—ESR2—lymphoid tissue—colon cancer	0.00215	0.0241	CbGeAlD
Estramustine—ESR2—digestive system—colon cancer	0.00213	0.0238	CbGeAlD
Estramustine—Tenderness—Fluorouracil—colon cancer	0.00196	0.014	CcSEcCtD
Estramustine—Lacrimation increased—Irinotecan—colon cancer	0.00194	0.0138	CcSEcCtD
Estramustine—MAP2—MAPK Cascade—NRAS—colon cancer	0.00193	0.0273	CbGpPWpGaD
Estramustine—Raised liver function tests—Methotrexate—colon cancer	0.00193	0.0138	CcSEcCtD
Estramustine—ESR1—epithelium—colon cancer	0.00192	0.0214	CbGeAlD
Estramustine—ESR2—vagina—colon cancer	0.00188	0.021	CbGeAlD
Estramustine—MAP2—lymph node—colon cancer	0.00187	0.021	CbGeAlD
Estramustine—Embolism—Capecitabine—colon cancer	0.00186	0.0133	CcSEcCtD
Estramustine—Lacrimation increased—Fluorouracil—colon cancer	0.00186	0.0133	CcSEcCtD
Estramustine—ESR1—smooth muscle tissue—colon cancer	0.00185	0.0206	CbGeAlD
Estramustine—ESR2—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00178	0.0252	CbGpPWpGaD
Estramustine—ESR1—renal system—colon cancer	0.00178	0.0199	CbGeAlD
Estramustine—Hypercalcaemia—Capecitabine—colon cancer	0.00172	0.0123	CcSEcCtD
Estramustine—MAP2—MAPK Cascade—KRAS—colon cancer	0.00166	0.0235	CbGpPWpGaD
Estramustine—ESR2—liver—colon cancer	0.00158	0.0177	CbGeAlD
Estramustine—ABCB1—blood vessel—colon cancer	0.00155	0.0174	CbGeAlD
Estramustine—Thrombophlebitis—Irinotecan—colon cancer	0.0015	0.0107	CcSEcCtD
Estramustine—ESR1—lymphoid tissue—colon cancer	0.00147	0.0165	CbGeAlD
Estramustine—ESR1—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.00147	0.0208	CbGpPWpGaD
Estramustine—ESR1—digestive system—colon cancer	0.00146	0.0163	CbGeAlD
Estramustine—Dysphonia—Capecitabine—colon cancer	0.00146	0.0104	CcSEcCtD
Estramustine—Thrombophlebitis—Fluorouracil—colon cancer	0.00144	0.0102	CcSEcCtD
Estramustine—MAP2—MAPK Cascade—HRAS—colon cancer	0.00141	0.02	CbGpPWpGaD
Estramustine—Embolism—Methotrexate—colon cancer	0.00139	0.0099	CcSEcCtD
Estramustine—Cerebrovascular accident—Irinotecan—colon cancer	0.00133	0.00945	CcSEcCtD
Estramustine—MAP2—LKB1 signaling events—MYC—colon cancer	0.00131	0.0186	CbGpPWpGaD
Estramustine—Lacrimation increased—Capecitabine—colon cancer	0.0013	0.00926	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.0013	0.00926	CcSEcCtD
Estramustine—ESR1—vagina—colon cancer	0.00129	0.0144	CbGeAlD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—AXIN2—colon cancer	0.00127	0.018	CbGpPWpGaD
Estramustine—Lethargy—Fluorouracil—colon cancer	0.00127	0.00905	CcSEcCtD
Estramustine—Cardiac arrest—Vincristine—colon cancer	0.00127	0.00904	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00124	0.00887	CcSEcCtD
Estramustine—Cardiac arrest—Irinotecan—colon cancer	0.00123	0.0088	CcSEcCtD
Estramustine—ESR2—lymph node—colon cancer	0.00122	0.0136	CbGeAlD
Estramustine—Cardiac arrest—Fluorouracil—colon cancer	0.00118	0.00843	CcSEcCtD
Estramustine—Skin exfoliation—Capecitabine—colon cancer	0.00114	0.00815	CcSEcCtD
Estramustine—Dry skin—Fluorouracil—colon cancer	0.00114	0.00813	CcSEcCtD
Estramustine—ESR1—Nuclear Receptors—HNF4A—colon cancer	0.00114	0.0161	CbGpPWpGaD
Estramustine—Pancytopenia—Vincristine—colon cancer	0.00109	0.0078	CcSEcCtD
Estramustine—ESR1—liver—colon cancer	0.00109	0.0121	CbGeAlD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00108	0.0153	CbGpPWpGaD
Estramustine—MAP2—LKB1 signaling events—TP53—colon cancer	0.00108	0.0153	CbGpPWpGaD
Estramustine—Erectile dysfunction—Vincristine—colon cancer	0.00106	0.00757	CcSEcCtD
Estramustine—Depression—Vincristine—colon cancer	0.00102	0.00731	CcSEcCtD
Estramustine—Pancytopenia—Fluorouracil—colon cancer	0.00102	0.00728	CcSEcCtD
Estramustine—Acute coronary syndrome—Vincristine—colon cancer	0.00101	0.00722	CcSEcCtD
Estramustine—Myocardial infarction—Vincristine—colon cancer	0.00101	0.00718	CcSEcCtD
Estramustine—Thrombophlebitis—Capecitabine—colon cancer	0.001	0.00716	CcSEcCtD
Estramustine—CYP3A4—renal system—colon cancer	0.000991	0.0111	CbGeAlD
Estramustine—Acute coronary syndrome—Irinotecan—colon cancer	0.000986	0.00703	CcSEcCtD
Estramustine—Myocardial infarction—Irinotecan—colon cancer	0.000981	0.00699	CcSEcCtD
Estramustine—ESR2—Nuclear Receptors—PPARG—colon cancer	0.00098	0.0139	CbGpPWpGaD
Estramustine—Eye pain—Capecitabine—colon cancer	0.000963	0.00686	CcSEcCtD
Estramustine—Acute coronary syndrome—Fluorouracil—colon cancer	0.000945	0.00674	CcSEcCtD
Estramustine—Myocardial infarction—Fluorouracil—colon cancer	0.000939	0.0067	CcSEcCtD
Estramustine—Libido decreased—Capecitabine—colon cancer	0.000937	0.00668	CcSEcCtD
Estramustine—Hot flush—Capecitabine—colon cancer	0.000929	0.00662	CcSEcCtD
Estramustine—ABCB1—embryo—colon cancer	0.000927	0.0104	CbGeAlD
Estramustine—Menopausal symptoms—Capecitabine—colon cancer	0.000921	0.00657	CcSEcCtD
Estramustine—Thirst—Capecitabine—colon cancer	0.000913	0.00651	CcSEcCtD
Estramustine—ESR1—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.0009	0.0127	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.000892	0.0126	CbGpPWpGaD
Estramustine—Cerebrovascular accident—Capecitabine—colon cancer	0.000887	0.00632	CcSEcCtD
Estramustine—Lethargy—Capecitabine—colon cancer	0.000887	0.00632	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000869	0.0062	CcSEcCtD
Estramustine—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000862	0.00615	CcSEcCtD
Estramustine—Estriol—ABCB1—colon cancer	0.000861	0.317	CrCbGaD
Estramustine—Skin exfoliation—Methotrexate—colon cancer	0.000851	0.00607	CcSEcCtD
Estramustine—Flushing—Irinotecan—colon cancer	0.000834	0.00594	CcSEcCtD
Estramustine—ESR1—lymph node—colon cancer	0.000832	0.00931	CbGeAlD
Estramustine—Cardiac arrest—Capecitabine—colon cancer	0.000826	0.00589	CcSEcCtD
Estramustine—Mood swings—Capecitabine—colon cancer	0.000823	0.00587	CcSEcCtD
Estramustine—Alopecia—Vincristine—colon cancer	0.000815	0.00581	CcSEcCtD
Estramustine—CYP3A4—digestive system—colon cancer	0.000813	0.00909	CbGeAlD
Estramustine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000805	0.0114	CbGpPWpGaD
Estramustine—Liver function test abnormal—Capecitabine—colon cancer	0.000802	0.00572	CcSEcCtD
Estramustine—Gynaecomastia—Methotrexate—colon cancer	0.000797	0.00569	CcSEcCtD
Estramustine—Dry skin—Capecitabine—colon cancer	0.000797	0.00568	CcSEcCtD
Estramustine—Alopecia—Irinotecan—colon cancer	0.000794	0.00566	CcSEcCtD
Estramustine—ESR2—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000775	0.011	CbGpPWpGaD
Estramustine—Flatulence—Irinotecan—colon cancer	0.000771	0.00549	CcSEcCtD
Estramustine—Alopecia—Fluorouracil—colon cancer	0.00076	0.00542	CcSEcCtD
Estramustine—ABCB1—epithelium—colon cancer	0.000756	0.00846	CbGeAlD
Estramustine—Muscle spasms—Irinotecan—colon cancer	0.000752	0.00536	CcSEcCtD
Estramustine—Thrombophlebitis—Methotrexate—colon cancer	0.000747	0.00533	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000737	0.0104	CbGpPWpGaD
Estramustine—Abdominal discomfort—Capecitabine—colon cancer	0.00072	0.00513	CcSEcCtD
Estramustine—ESR1—Estrogen signaling pathway—BRAF—colon cancer	0.000719	0.0102	CbGpPWpGaD
Estramustine—Leukopenia—Vincristine—colon cancer	0.000719	0.00513	CcSEcCtD
Estramustine—Pancytopenia—Capecitabine—colon cancer	0.000713	0.00509	CcSEcCtD
Estramustine—ABCB1—renal system—colon cancer	0.000702	0.00785	CbGeAlD
Estramustine—Leukopenia—Irinotecan—colon cancer	0.0007	0.00499	CcSEcCtD
Estramustine—Leukopenia—Fluorouracil—colon cancer	0.00067	0.00478	CcSEcCtD
Estramustine—Depression—Capecitabine—colon cancer	0.000668	0.00476	CcSEcCtD
Estramustine—Acute coronary syndrome—Capecitabine—colon cancer	0.00066	0.00471	CcSEcCtD
Estramustine—Lethargy—Methotrexate—colon cancer	0.00066	0.00471	CcSEcCtD
Estramustine—Cerebrovascular accident—Methotrexate—colon cancer	0.00066	0.00471	CcSEcCtD
Estramustine—Myocardial infarction—Capecitabine—colon cancer	0.000656	0.00468	CcSEcCtD
Estramustine—Oedema—Vincristine—colon cancer	0.000655	0.00467	CcSEcCtD
Estramustine—Thrombocytopenia—Vincristine—colon cancer	0.000642	0.00458	CcSEcCtD
Estramustine—Oedema—Irinotecan—colon cancer	0.000638	0.00455	CcSEcCtD
Estramustine—Chest pain—Fluorouracil—colon cancer	0.000638	0.00455	CcSEcCtD
Estramustine—Thrombocytopenia—Irinotecan—colon cancer	0.000625	0.00446	CcSEcCtD
Estramustine—Anorexia—Vincristine—colon cancer	0.000625	0.00445	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—HNF4A—colon cancer	0.000621	0.00879	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00062	0.00877	CbGpPWpGaD
Estramustine—Mood swings—Methotrexate—colon cancer	0.000613	0.00437	CcSEcCtD
Estramustine—Oedema—Fluorouracil—colon cancer	0.000611	0.00436	CcSEcCtD
Estramustine—Anorexia—Irinotecan—colon cancer	0.000608	0.00434	CcSEcCtD
Estramustine—CYP3A4—liver—colon cancer	0.000606	0.00677	CbGeAlD
Estramustine—MAP2—SIDS Susceptibility Pathways—CASP3—colon cancer	0.0006	0.00848	CbGpPWpGaD
Estramustine—Thrombocytopenia—Fluorouracil—colon cancer	0.000598	0.00427	CcSEcCtD
Estramustine—Liver function test abnormal—Methotrexate—colon cancer	0.000597	0.00426	CcSEcCtD
Estramustine—Insomnia—Vincristine—colon cancer	0.000593	0.00423	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—SRC—colon cancer	0.000587	0.0083	CbGpPWpGaD
Estramustine—Anorexia—Fluorouracil—colon cancer	0.000583	0.00415	CcSEcCtD
Estramustine—ABCB1—lymphoid tissue—colon cancer	0.000583	0.00652	CbGeAlD
Estramustine—MAP2—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000578	0.00818	CbGpPWpGaD
Estramustine—Insomnia—Irinotecan—colon cancer	0.000577	0.00412	CcSEcCtD
Estramustine—ABCB1—digestive system—colon cancer	0.000575	0.00644	CbGeAlD
Estramustine—Decreased appetite—Vincristine—colon cancer	0.00057	0.00406	CcSEcCtD
Estramustine—Dyspnoea—Irinotecan—colon cancer	0.000569	0.00406	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—NRAS—colon cancer	0.000565	0.00798	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000562	0.00796	CbGpPWpGaD
Estramustine—Tinnitus—Capecitabine—colon cancer	0.000561	0.004	CcSEcCtD
Estramustine—Flushing—Capecitabine—colon cancer	0.000558	0.00398	CcSEcCtD
Estramustine—Decreased appetite—Irinotecan—colon cancer	0.000555	0.00396	CcSEcCtD
Estramustine—Insomnia—Fluorouracil—colon cancer	0.000553	0.00394	CcSEcCtD
Estramustine—Dyspnoea—Fluorouracil—colon cancer	0.000545	0.00389	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000545	0.0077	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—EP300—colon cancer	0.000537	0.0076	CbGpPWpGaD
Estramustine—Abdominal discomfort—Methotrexate—colon cancer	0.000536	0.00382	CcSEcCtD
Estramustine—Decreased appetite—Fluorouracil—colon cancer	0.000531	0.00379	CcSEcCtD
Estramustine—Alopecia—Capecitabine—colon cancer	0.000531	0.00379	CcSEcCtD
Estramustine—Pancytopenia—Methotrexate—colon cancer	0.000531	0.00379	CcSEcCtD
Estramustine—ABCB1—bone marrow—colon cancer	0.00053	0.00593	CbGeAlD
Estramustine—Flatulence—Capecitabine—colon cancer	0.000516	0.00368	CcSEcCtD
Estramustine—Erectile dysfunction—Methotrexate—colon cancer	0.000515	0.00367	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000509	0.0072	CbGpPWpGaD
Estramustine—ABCB1—vagina—colon cancer	0.000508	0.00568	CbGeAlD
Estramustine—Muscle spasms—Capecitabine—colon cancer	0.000503	0.00359	CcSEcCtD
Estramustine—Depression—Methotrexate—colon cancer	0.000497	0.00354	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000496	0.00701	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptors—PPARG—colon cancer	0.000494	0.00699	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—KRAS—colon cancer	0.000486	0.00687	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MSH6—colon cancer	0.000485	0.00687	CbGpPWpGaD
Estramustine—Ethinyl Estradiol—ABCB1—colon cancer	0.00047	0.173	CrCbGaD
Estramustine—Leukopenia—Capecitabine—colon cancer	0.000468	0.00334	CcSEcCtD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—colon cancer	0.000459	0.00649	CbGpPWpGaD
Estramustine—Diarrhoea—Vincristine—colon cancer	0.000448	0.0032	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—PIK3CA—colon cancer	0.000446	0.00631	CbGpPWpGaD
Estramustine—Chest pain—Capecitabine—colon cancer	0.000446	0.00318	CcSEcCtD
Estramustine—Anxiety—Capecitabine—colon cancer	0.000444	0.00317	CcSEcCtD
Estramustine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000441	0.00623	CbGpPWpGaD
Estramustine—Diarrhoea—Irinotecan—colon cancer	0.000437	0.00311	CcSEcCtD
Estramustine—Pruritus—Fluorouracil—colon cancer	0.000432	0.00308	CcSEcCtD
Estramustine—ABCB1—liver—colon cancer	0.000429	0.00479	CbGeAlD
Estramustine—Oedema—Capecitabine—colon cancer	0.000427	0.00305	CcSEcCtD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—EP300—colon cancer	0.000423	0.00598	CbGpPWpGaD
Estramustine—Diarrhoea—Fluorouracil—colon cancer	0.000418	0.00298	CcSEcCtD
Estramustine—Thrombocytopenia—Capecitabine—colon cancer	0.000418	0.00298	CcSEcCtD
Estramustine—Tinnitus—Methotrexate—colon cancer	0.000417	0.00298	CcSEcCtD
Estramustine—Vomiting—Vincristine—colon cancer	0.000417	0.00297	CcSEcCtD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—colon cancer	0.000415	0.00587	CbGpPWpGaD
Estramustine—Rash—Vincristine—colon cancer	0.000413	0.00295	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—HRAS—colon cancer	0.000413	0.00584	CbGpPWpGaD
Estramustine—Dermatitis—Vincristine—colon cancer	0.000413	0.00294	CcSEcCtD
Estramustine—Conjugated Estrogens—ABCB1—colon cancer	0.000411	0.151	CrCbGaD
Estramustine—Headache—Vincristine—colon cancer	0.000411	0.00293	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—BCL2L1—colon cancer	0.00041	0.0058	CbGpPWpGaD
Estramustine—Estrone—ABCB1—colon cancer	0.00041	0.151	CrCbGaD
Estramustine—Anorexia—Capecitabine—colon cancer	0.000407	0.0029	CcSEcCtD
Estramustine—Vomiting—Irinotecan—colon cancer	0.000406	0.00289	CcSEcCtD
Estramustine—Rash—Irinotecan—colon cancer	0.000402	0.00287	CcSEcCtD
Estramustine—Dermatitis—Irinotecan—colon cancer	0.000402	0.00287	CcSEcCtD
Estramustine—Headache—Irinotecan—colon cancer	0.0004	0.00285	CcSEcCtD
Estramustine—Alopecia—Methotrexate—colon cancer	0.000395	0.00282	CcSEcCtD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MSH2—colon cancer	0.000394	0.00557	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000391	0.00552	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—BAX—colon cancer	0.00039	0.00552	CbGpPWpGaD
Estramustine—Nausea—Vincristine—colon cancer	0.000389	0.00278	CcSEcCtD
Estramustine—Vomiting—Fluorouracil—colon cancer	0.000389	0.00277	CcSEcCtD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000387	0.00548	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000387	0.00548	CbGpPWpGaD
Estramustine—Insomnia—Capecitabine—colon cancer	0.000386	0.00275	CcSEcCtD
Estramustine—Rash—Fluorouracil—colon cancer	0.000385	0.00275	CcSEcCtD
Estramustine—Dermatitis—Fluorouracil—colon cancer	0.000385	0.00275	CcSEcCtD
Estramustine—Headache—Fluorouracil—colon cancer	0.000383	0.00273	CcSEcCtD
Estramustine—Dyspnoea—Capecitabine—colon cancer	0.000381	0.00272	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00038	0.00538	CbGpPWpGaD
Estramustine—Nausea—Irinotecan—colon cancer	0.000379	0.0027	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000372	0.00526	CbGpPWpGaD
Estramustine—Decreased appetite—Capecitabine—colon cancer	0.000371	0.00265	CcSEcCtD
Estramustine—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000371	0.00525	CbGpPWpGaD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	0.000368	0.00521	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000366	0.00518	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—AKT1—colon cancer	0.000365	0.00516	CbGpPWpGaD
Estramustine—Nausea—Fluorouracil—colon cancer	0.000363	0.00259	CcSEcCtD
Estramustine—ESR1—Estrogen signaling pathway—PIK3CA—colon cancer	0.000357	0.00506	CbGpPWpGaD
Estramustine—Leukopenia—Methotrexate—colon cancer	0.000349	0.00249	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—BCL2L1—colon cancer	0.000339	0.00479	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	0.000334	0.00472	CbGpPWpGaD
Estramustine—Chest pain—Methotrexate—colon cancer	0.000332	0.00237	CcSEcCtD
Estramustine—ABCB1—lymph node—colon cancer	0.000329	0.00368	CbGeAlD
Estramustine—ESR1—FOXM1 transcription factor network—CCND1—colon cancer	0.000324	0.00459	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000313	0.00442	CbGpPWpGaD
Estramustine—Thrombocytopenia—Methotrexate—colon cancer	0.000311	0.00222	CcSEcCtD
Estramustine—Estradiol—ABCB1—colon cancer	0.00031	0.114	CrCbGaD
Estramustine—ESR2—Generic Transcription Pathway—HNF4A—colon cancer	0.000308	0.00436	CbGpPWpGaD
Estramustine—Anorexia—Methotrexate—colon cancer	0.000303	0.00216	CcSEcCtD
Estramustine—Pruritus—Capecitabine—colon cancer	0.000302	0.00215	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—EP300—colon cancer	0.000298	0.00422	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—SRC—colon cancer	0.000296	0.00419	CbGpPWpGaD
Estramustine—Diarrhoea—Capecitabine—colon cancer	0.000292	0.00208	CcSEcCtD
Estramustine—ESR1—Estrogen signaling pathway—AKT1—colon cancer	0.000292	0.00413	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.000292	0.00413	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000288	0.00408	CbGpPWpGaD
Estramustine—Insomnia—Methotrexate—colon cancer	0.000288	0.00205	CcSEcCtD
Estramustine—ESR1—FOXA1 transcription factor network—EP300—colon cancer	0.000288	0.00407	CbGpPWpGaD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000286	0.00404	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—NRAS—colon cancer	0.000285	0.00403	CbGpPWpGaD
Estramustine—Dyspnoea—Methotrexate—colon cancer	0.000283	0.00202	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000279	0.00395	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.000278	0.00393	CbGpPWpGaD
Estramustine—Decreased appetite—Methotrexate—colon cancer	0.000276	0.00197	CcSEcCtD
Estramustine—Vomiting—Capecitabine—colon cancer	0.000272	0.00194	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.00027	0.00382	CbGpPWpGaD
Estramustine—Rash—Capecitabine—colon cancer	0.000269	0.00192	CcSEcCtD
Estramustine—Dermatitis—Capecitabine—colon cancer	0.000269	0.00192	CcSEcCtD
Estramustine—Headache—Capecitabine—colon cancer	0.000268	0.00191	CcSEcCtD
Estramustine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000266	0.00376	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000263	0.00372	CbGpPWpGaD
Estramustine—ESR1—FOXM1 transcription factor network—MYC—colon cancer	0.00026	0.00368	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.00026	0.00367	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000258	0.00365	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—MYC—colon cancer	0.000255	0.00361	CbGpPWpGaD
Estramustine—Nausea—Capecitabine—colon cancer	0.000254	0.00181	CcSEcCtD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000253	0.00358	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00025	0.00354	CbGpPWpGaD
Estramustine—Testosterone—ABCB1—colon cancer	0.000249	0.0919	CrCbGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	0.000247	0.0035	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—CCND1—colon cancer	0.000247	0.00349	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—KRAS—colon cancer	0.000245	0.00347	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000242	0.00342	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000237	0.00335	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—colon cancer	0.000232	0.00327	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000231	0.00327	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—EP300—colon cancer	0.000227	0.00322	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—colon cancer	0.000225	0.00318	CbGpPWpGaD
Estramustine—Pruritus—Methotrexate—colon cancer	0.000225	0.0016	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000223	0.00316	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000223	0.00315	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—BAX—colon cancer	0.000223	0.00315	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—CCND1—colon cancer	0.000221	0.00312	CbGpPWpGaD
Estramustine—Diarrhoea—Methotrexate—colon cancer	0.000218	0.00155	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—CCND1—colon cancer	0.000215	0.00305	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CTNNB1—colon cancer	0.000213	0.00302	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—EP300—colon cancer	0.000213	0.00301	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000212	0.003	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—TP53—colon cancer	0.00021	0.00296	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—HRAS—colon cancer	0.000208	0.00295	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—EP300—colon cancer	0.000207	0.00293	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—CCND1—colon cancer	0.000204	0.00288	CbGpPWpGaD
Estramustine—Vomiting—Methotrexate—colon cancer	0.000202	0.00144	CcSEcCtD
Estramustine—Rash—Methotrexate—colon cancer	0.0002	0.00143	CcSEcCtD
Estramustine—Dermatitis—Methotrexate—colon cancer	0.0002	0.00143	CcSEcCtD
Estramustine—Headache—Methotrexate—colon cancer	0.000199	0.00142	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—EP300—colon cancer	0.000198	0.00281	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000197	0.00278	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000197	0.00278	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000196	0.00278	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000195	0.00276	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000192	0.00271	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000191	0.00271	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.00019	0.00269	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.00019	0.00268	CbGpPWpGaD
Estramustine—Nausea—Methotrexate—colon cancer	0.000189	0.00135	CcSEcCtD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	0.000186	0.00263	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000185	0.00262	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000185	0.00262	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000185	0.00261	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—FGFR3—colon cancer	0.000184	0.0026	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—AKT1—colon cancer	0.000184	0.0026	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—SRC—colon cancer	0.000183	0.00258	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—MYC—colon cancer	0.000177	0.0025	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000176	0.0025	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—TGFB1—colon cancer	0.000176	0.0025	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000176	0.00249	CbGpPWpGaD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000176	0.00249	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—EGFR—colon cancer	0.000173	0.00245	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MYC—colon cancer	0.000173	0.00244	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TGFB1—colon cancer	0.000172	0.00244	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000171	0.00242	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000167	0.00236	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000166	0.00234	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.00016	0.00226	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000156	0.00221	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—HNF4A—colon cancer	0.000155	0.0022	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000154	0.00218	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000154	0.00217	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000153	0.00217	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.00015	0.00212	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—HNF4A—colon cancer	0.000148	0.0021	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—colon cancer	0.000142	0.00201	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000142	0.00201	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000141	0.00199	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—PPARG—colon cancer	0.000134	0.00189	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000132	0.00187	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.00013	0.00184	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—HRAS—colon cancer	0.000128	0.00182	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000126	0.00178	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—AKT1—colon cancer	0.000123	0.00174	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—DLC1—colon cancer	0.000122	0.00173	CbGpPWpGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	0.000122	0.00172	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CA7—colon cancer	0.00012	0.0017	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.00012	0.00169	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000117	0.00165	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000115	0.00163	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—LGR5—colon cancer	0.000115	0.00162	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—AKT1—colon cancer	0.000113	0.0016	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—CDKN1A—colon cancer	0.000112	0.00159	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	0.00011	0.00156	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000107	0.00152	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000107	0.00151	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000107	0.00151	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000106	0.00151	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CASP3—colon cancer	0.000106	0.0015	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.000104	0.00147	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000102	0.00144	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000101	0.00143	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—NRAS—colon cancer	9.98e-05	0.00141	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	9.92e-05	0.0014	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	9.77e-05	0.00138	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	9.65e-05	0.00137	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	9.56e-05	0.00135	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MYC—colon cancer	9.34e-05	0.00132	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	9.34e-05	0.00132	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EGFR—colon cancer	9.14e-05	0.00129	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—EGFR—colon cancer	9.09e-05	0.00129	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—VEGFA—colon cancer	9.02e-05	0.00128	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	8.89e-05	0.00126	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	8.64e-05	0.00122	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—KRAS—colon cancer	8.63e-05	0.00122	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—KRAS—colon cancer	8.59e-05	0.00121	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	8.42e-05	0.00119	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TGFB1—colon cancer	8.28e-05	0.00117	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AXIN2—colon cancer	8.25e-05	0.00117	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PIK3CA—colon cancer	7.89e-05	0.00112	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	7.74e-05	0.0011	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	7.72e-05	0.00109	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—colon cancer	7.67e-05	0.00109	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—MYC—colon cancer	7.63e-05	0.00108	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	7.57e-05	0.00107	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—HNF4A—colon cancer	7.48e-05	0.00106	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	7.45e-05	0.00105	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CA7—colon cancer	7.39e-05	0.00105	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—HRAS—colon cancer	7.3e-05	0.00103	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ODC1—colon cancer	7.27e-05	0.00103	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CHST5—colon cancer	7.27e-05	0.00103	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	7.15e-05	0.00101	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—PPARG—colon cancer	6.75e-05	0.000954	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	6.65e-05	0.00094	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	6.57e-05	0.00093	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—AKT1—colon cancer	6.48e-05	0.000917	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—AKT1—colon cancer	6.45e-05	0.000912	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PPARG—colon cancer	6.44e-05	0.000911	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	6.36e-05	0.000899	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	5.65e-05	0.0008	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.37e-05	0.000759	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	5.25e-05	0.000742	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	5.11e-05	0.000722	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	5.06e-05	0.000715	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	4.94e-05	0.000699	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	4.7e-05	0.000665	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	4.57e-05	0.000647	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ODC1—colon cancer	4.48e-05	0.000633	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CHST5—colon cancer	4.48e-05	0.000633	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	4.45e-05	0.00063	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	4.1e-05	0.000579	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	4.09e-05	0.000578	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	4.01e-05	0.000567	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—MYC—colon cancer	3.85e-05	0.000544	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	3.79e-05	0.000535	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MYC—colon cancer	3.67e-05	0.000519	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.48e-05	0.000492	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3.36e-05	0.000476	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PPARG—colon cancer	3.25e-05	0.000459	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	2.84e-05	0.000402	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—AKT1—colon cancer	2.55e-05	0.00036	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGFR3—colon cancer	2.38e-05	0.000337	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—APC—colon cancer	2.19e-05	0.00031	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—BRAF—colon cancer	2.06e-05	0.000291	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TYMS—colon cancer	1.89e-05	0.000267	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MYC—colon cancer	1.85e-05	0.000262	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CASP3—colon cancer	1.54e-05	0.000218	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCND1—colon cancer	1.5e-05	0.000212	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CTNNB1—colon cancer	1.49e-05	0.00021	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDKN1A—colon cancer	1.45e-05	0.000205	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EP300—colon cancer	1.38e-05	0.000195	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SRC—colon cancer	1.34e-05	0.00019	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PPARG—colon cancer	1.34e-05	0.000189	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VEGFA—colon cancer	1.31e-05	0.000185	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NRAS—colon cancer	1.29e-05	0.000183	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—AKT1—colon cancer	1.28e-05	0.000182	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MYC—colon cancer	1.2e-05	0.00017	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TGFB1—colon cancer	1.2e-05	0.00017	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ABCB1—colon cancer	1.18e-05	0.000167	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGFR—colon cancer	1.18e-05	0.000167	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TYMS—colon cancer	1.16e-05	0.000164	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KRAS—colon cancer	1.11e-05	0.000157	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS2—colon cancer	1.05e-05	0.000149	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CA—colon cancer	1.02e-05	0.000145	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—colon cancer	9.89e-06	0.00014	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HRAS—colon cancer	9.46e-06	0.000134	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—EP300—colon cancer	8.74e-06	0.000124	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKT1—colon cancer	8.35e-06	0.000118	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PPARG—colon cancer	8.23e-06	0.000116	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS2—colon cancer	6.48e-06	9.16e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CA—colon cancer	6.47e-06	9.15e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—EP300—colon cancer	5.39e-06	7.62e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AKT1—colon cancer	5.28e-06	7.47e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CA—colon cancer	3.98e-06	5.64e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AKT1—colon cancer	3.26e-06	4.6e-05	CbGpPWpGaD
